Community-based practice of early lung cancer screening with low-dose spiral computed tomography in Jiaxing city from Zhejiang Province.

2020 ◽  
Vol 38 (15_suppl) ◽  
pp. e13557-e13557
Author(s):  
You-cai Zhu ◽  
Wen xian Wang ◽  
Chunwei Xu ◽  
Gang Lan ◽  
Huafei Chen ◽  
...  

e13557 Background: As one of the most frequent malignant tumors in China, the morbidity and mortality of lung cancer remain high. Early diagnosis and normative treatment is the key to improve the prognosis of lung cancer. The aim of this study is to explore the practice of early lung cancer screening with low-dose spiral computed tomography (CT) based on the current situation in community health service, with integration of superior resources of medical institutions at all levels in Jiaxing City from Zhejiang Province. Methods: From Jan. 2017 to Dec. 2019, we screened 13491 (male 8783, female 4708) individuals high-risk population in selected communities of Nanhu District, Pinghu County and Haiyan County, Zhejiang Province, for early diagnosis of lung cancer with low-dose spiral CT combined with multidisciplinary comprehensive treatment models including minimally invasive surgery, exploring the medical service network covering prevention, diagnosis, treatment, rehabilitation and follow-up. Results: Screening resulted in a diagnosis of cancer in 27 participants. Of these participants, 24 cases of primary lung cancer, 1 case of lung metastasis, 1 case of breast cancer, 1 case of thyroid cancer. The morbidity of primary lung cancer is 224.53×10-5. There were 20 cases of Stage 0-Ⅰlung cancer accounting for 83.33% of all diagnosed primary lung cancer. Conclusions: Based on community health service, screening with LDCT could improve the early diagnosis rate of lung cancer in both smokers and nonsmokers with feasibility and validity, which could be applicable in qualified eligible medical centers and communities in China. It is not reasonable to exclude nonsmokers from screening with LDCT.

The Lancet ◽  
1998 ◽  
Vol 352 (9123) ◽  
pp. 235 ◽  
Author(s):  
Sarah Conolly ◽  
Sarah Hearnshaw ◽  
Sarah Low ◽  
Richard Edwards

2013 ◽  
Vol 31 (15_suppl) ◽  
pp. 1564-1564 ◽  
Author(s):  
Robert J. Volk ◽  
Suzanne K. Linder ◽  
Viola Leal ◽  
Vance A. Rabius ◽  
Paul M. Cinciripini ◽  
...  

1564 Background: Results from the National Lung Screening Trial (NLST) and a recent ASCO-supported systematic review concluded that screening with low-dose spiral computed tomography (LDCT) reduces lung cancer deaths among selected heavy smokers. Yet, this mortality benefit must be weighed against the potential harms of screening (e.g., high false positive rate). In anticipation of LDCT screening becoming a reimbursable preventive health service, we developed and evaluated a brief, video-based patient decision aid designed for use in clinical settings. Methods: Patients from a tobacco treatment program who were 45 to 75 years of age and had no history of lung cancer participated in the study. Measures of acceptability and ratings of the aid were included. We assessed effectiveness of the aid via knowledge about lung cancer and the benefits and risks of screening, and clarity of values using the Decisional Conflict Scale. Results: Fifty-two patients completed the study (mean age=58.5 years; mean average years smoking=34.8 years). Over 94% of patients watched the entire video, would recommend it to others, felt it held their interest, rated the content favorably, and wanted to view similar video-based aids. Acceptability was high, although 23.3% wanted more information about the NLST findings and evidence base. After viewing the aid, knowledge about lung cancer screening increased significantly (before viewing aid, 25.5% of questions answered correctly; after viewing aid, 74.8%; P<.01). The majority of patients continued to have difficulty with the question about whether all current and former smokers should be screened for lung cancer (23.1% answered correctly). Patients reported being clear about which benefits and harms of screening mattered most to them (94.1% and 86.5% were clear, respectively). Conclusions: Our decision aid was rated favorably by tobacco treatment patients. Large gains in knowledge about lung cancer screening were observed, highlighting the important informational function of the aid. Additional features under consideration for the aid include screening eligibility assessment and information about the evidence behind the screening recommendations.


2017 ◽  
Vol 26 (4) ◽  
pp. 324-329 ◽  
Author(s):  
Maurizio Infante ◽  
Stefano Sestini ◽  
Carlotta Galeone ◽  
Alfonso Marchianò ◽  
Fabio R. Lutman ◽  
...  

2001 ◽  
Vol 18 (5) ◽  
pp. 857-866 ◽  
Author(s):  
R.J. van Klaveren ◽  
J.D.F. Habbema ◽  
J.H. Pedersen ◽  
H.J. de Koning ◽  
M. Oudkerk ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document